Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
300841 Chengdu Kanghua Biological Products
- 58.21
- +0.59+1.02%
Market Closed Dec 12 15:00 CST
7.84BMarket Cap14.35P/E (TTM)
58.28High57.25Low22.22KlotVolume57.62Open57.62Pre Close128.40MTurnover1.82%Turnover Ratio15.39P/E (Static)134.65MShares79.0052wk High2.27P/B7.12BFloat Cap42.8152wk Low69.14Limit Up122.23MShs Float439.88Historical High46.10Limit Down1.79%Amplitude33.51Historical Low2.00Dividend TTM57.77Avg Price9.40KlotAsk3.44%Div YieldTTM100Lot Size11.91KlotBid
Chengdu Kanghua Biological Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 1.58%762.34M | 19.06%770.07M | 58.78%1.01B | 59.54%1.04B | 28.82%750.49M | 1.76%646.79M | -6.43%634.73M | -29.71%651.46M | -28.21%582.59M | -30.27%635.63M |
| Transactional financial assets | ---- | ---- | --50M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 5.78%1.39B | 7.96%1.43B | 4.24%1.36B | 9.59%1.41B | 8.75%1.32B | 20.71%1.32B | 38.18%1.31B | 53.74%1.29B | 95.71%1.21B | 77.99%1.1B |
| -Notes receivable | --700K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | 5.72%1.39B | 7.96%1.43B | 4.24%1.36B | 9.59%1.41B | 8.75%1.32B | 20.71%1.32B | 38.18%1.31B | 53.74%1.29B | 95.71%1.21B | 77.99%1.1B |
| Other receivables (including interest and dividends) | -24.20%13.29M | -23.45%13.26M | -8.53%16.95M | -7.57%16.38M | -10.79%17.53M | -10.76%17.32M | 484.36%18.53M | 587.09%17.72M | 614.35%19.65M | 631.99%19.41M |
| -Other receivable | ---- | -23.45%13.26M | ---- | ---- | ---- | -10.76%17.32M | ---- | 587.09%17.72M | ---- | 631.99%19.41M |
| Advance payment | -52.94%10.57M | -54.96%13.32M | -38.99%18.91M | -51.43%17.09M | -58.00%22.46M | -59.93%29.58M | -71.79%31M | -49.96%35.19M | -30.00%53.47M | 63.06%73.82M |
| Inventories | -2.02%180.44M | 1.34%193.76M | 2.02%189.11M | 12.95%173.54M | 19.78%184.16M | 15.55%191.19M | 28.77%185.37M | 45.65%153.65M | 95.94%153.75M | 175.70%165.46M |
| Other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --103.22K | --204.28K |
| Total current assets | 2.97%2.36B | 9.55%2.42B | 21.54%2.64B | 23.86%2.66B | 13.42%2.29B | 10.92%2.21B | 9.83%2.18B | 10.42%2.15B | 18.32%2.02B | 11.53%1.99B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -11.19%461.75M | -11.08%466.29M | -8.56%471.39M | -6.29%470.87M | 12.47%519.91M | 16.51%524.41M | 7.15%515.52M | 7.23%502.47M | 5.66%462.27M | 140.84%450.11M |
| Long-term equity investment | --6.5M | --6.5M | --6.5M | --6.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | 64.62%825.97M | ---- | ---- | ---- | 73.88%501.73M | ---- | 85.76%461.66M | ---- | 248.44%288.55M |
| Constru in process | ---- | -74.48%119.38M | ---- | ---- | ---- | 73.04%467.87M | ---- | 119.24%523.35M | ---- | 75.10%270.38M |
| Intangible assets | -1.21%15.83M | -2.88%15.78M | -11.18%15.37M | -10.78%15.38M | -7.99%16.02M | -12.46%16.24M | -7.49%17.31M | -8.17%17.23M | -10.18%17.41M | -6.83%18.56M |
| Long deferred expense | 9.65%137.02M | 57.14%117.42M | 96.52%107.01M | 75.58%94.39M | 137.21%124.97M | 95.60%74.72M | 46.07%54.45M | 49.05%53.76M | 50.86%52.68M | 6.86%38.2M |
| Deferred tax assets | --525.07K | --1.25M | ---- | ---- | ---- | ---- | ---- | ---- | 615.22%10.66M | 1,693.57%19.79M |
| Usufruct assets | ---- | ---- | ---- | ---- | ---- | -80.00%149.37K | -73.13%298.74K | -69.82%448.11K | -67.83%597.48K | -66.52%746.85K |
| Other non current assets | -48.87%3.99M | -40.01%6.56M | -2.03%7.45M | -44.08%3.94M | -95.04%7.81M | -91.85%10.94M | -89.28%7.6M | -87.47%7.05M | 18.35%157.52M | 123.61%134.26M |
| Total non current assets | -2.00%1.59B | -2.31%1.56B | -1.10%1.56B | -0.87%1.55B | 20.37%1.62B | 30.76%1.6B | 40.42%1.57B | 45.61%1.57B | 45.41%1.35B | 124.72%1.22B |
| Total assets | 0.91%3.95B | 4.58%3.98B | 12.03%4.2B | 13.42%4.21B | 16.20%3.92B | 18.46%3.81B | 20.89%3.75B | 22.96%3.71B | 27.85%3.37B | 37.93%3.21B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 71.95%216.43M | 27.03%176.4M | 71.80%210.19M | 74.68%190.91M | -6.33%125.87M | 4.97%138.86M | 205.86%122.35M | --109.3M | --134.38M | --132.28M |
| Notes payable and accounts payable | -82.81%6.15M | -87.54%6.22M | -70.26%11.27M | -79.12%7.13M | 19.17%35.78M | 128.00%49.89M | 91.17%37.9M | 463.57%34.14M | 411.46%30.03M | 78.09%21.88M |
| -Notes payable | -96.19%937.62K | ---- | ---- | -77.53%4M | 61.80%24.6M | 521.71%37.7M | --22.06M | --17.8M | --15.2M | --6.06M |
| -Accounts payable | -53.37%5.21M | -49.00%6.22M | -28.82%11.27M | -80.85%3.13M | -24.56%11.18M | -22.92%12.19M | -20.14%15.83M | 169.68%16.34M | 152.47%14.82M | 28.74%15.82M |
| Contract liabilities | -68.49%105.61K | -41.76%207.37K | 118.31%184.51K | 26.29%295.51K | 1.79%335.17K | 664.04%356.06K | -75.34%84.52K | --234K | --329.27K | --46.6K |
| Salaries payable | -20.13%20.62M | 21.23%17.4M | 37.39%14.37M | 23.47%34.94M | 45.24%25.81M | -18.21%14.35M | -10.83%10.46M | 13.61%28.3M | 57.32%17.77M | 54.37%17.54M |
| Taxs payable | -28.05%11.78M | 16.47%22.47M | 6.43%17.14M | 81.75%42.22M | -28.34%16.37M | -53.53%19.3M | 8.03%16.11M | -33.90%23.23M | -17.96%22.84M | 13.65%41.52M |
| Other payable (including interest and dividends) | -24.81%230.95M | 2.12%306.56M | -6.03%335.36M | -2.16%406.22M | 63.95%307.16M | 63.30%300.19M | 78.42%356.87M | 52.51%415.19M | 70.50%187.35M | 49.73%183.83M |
| -Other payable | ---- | 2.12%306.56M | ---- | ---- | ---- | 63.30%300.19M | ---- | 52.51%415.19M | ---- | 49.73%183.83M |
| Non current liabilities due within one year | ---- | ---- | ---- | ---- | 118.74%1M | 64.36%1M | 92.38%1.15M | 120.15%1.31M | -55.57%457.17K | -58.53%608.4K |
| Other current liabilities | -68.49%3.17K | 17.79%6.22K | 114.34%5.54K | 26.29%8.87K | 1.79%10.06K | 277.79%5.28K | --2.58K | --7.02K | --9.88K | --1.4K |
| Total current liabilities | -5.13%486.03M | 1.01%529.26M | 8.00%588.53M | 11.45%681.72M | 30.31%512.33M | 31.74%523.96M | 89.59%544.93M | 80.48%611.71M | 152.16%393.16M | 115.65%397.71M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | --15.25M | --15.25M | --15.75M | --15.75M | ---- | ---- |
| Estimate liabilities | 5.50%3.81M | 0.18%3.22M | 18.34%4.02M | 20.33%4.79M | -34.17%3.61M | -48.45%3.22M | -14.34%3.4M | 5.71%3.98M | 98.90%5.48M | 122.65%6.24M |
| Deferred tax liabilities | ---- | ---- | -61.01%1.9M | -36.86%2.5M | -24.34%4.91M | -19.51%4.96M | -26.36%4.87M | -16.30%3.96M | --6.48M | --6.16M |
| Long term deferred income | 7,198.92%6.17M | --6.18M | --6.2M | --6.2M | --84.49K | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | -58.17%9.98M | -59.85%9.4M | -49.54%12.12M | -43.05%13.49M | 99.25%23.85M | 88.91%23.42M | 123.71%24.02M | 169.08%23.69M | 272.41%11.97M | 263.86%12.4M |
| Total liabilities | -7.49%496.01M | -1.59%538.67M | 5.57%600.65M | 9.41%695.22M | 32.35%536.18M | 33.47%547.38M | 90.81%568.94M | 82.72%635.4M | 154.59%405.13M | 118.34%410.11M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M | 49.61%134.65M | 49.61%134.65M | 49.61%134.65M | 49.61%134.65M |
| Capital reserve funds | -0.44%1.18B | -0.44%1.18B | -0.39%1.18B | -0.33%1.18B | -0.18%1.18B | -0.07%1.18B | -3.23%1.18B | -2.98%1.18B | -2.40%1.19B | -2.21%1.19B |
| Surplus reserve funds | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 49.61%67.33M | 49.61%67.33M | 49.61%67.33M | 49.61%67.33M | 50.00%45M | 50.00%45M |
| Retained profit | 13.28%2.4B | 15.16%2.3B | 25.36%2.41B | 24.39%2.26B | 22.92%2.12B | 28.42%1.99B | 27.34%1.92B | 32.23%1.81B | 50.93%1.72B | 91.99%1.55B |
| Less:Treasury stock | 162.47%323.1M | 92.91%237.47M | 50.72%185.53M | 0.00%123.1M | 0.00%123.1M | 6.14%123.1M | 101.83%123.1M | 120.27%123.1M | --123.1M | --115.98M |
| Shareholders equity without minority interests | 2.24%3.45B | 5.61%3.44B | 13.19%3.6B | 14.25%3.51B | 13.99%3.38B | 16.27%3.26B | 13.45%3.18B | 15.18%3.08B | 19.71%2.96B | 30.87%2.8B |
| Total shareholder equity | 2.24%3.45B | 5.61%3.44B | 13.19%3.6B | 14.25%3.51B | 13.99%3.38B | 16.27%3.26B | 13.45%3.18B | 15.18%3.08B | 19.71%2.96B | 30.87%2.8B |
| Total liabilityies and equity | 0.91%3.95B | 4.58%3.98B | 12.03%4.2B | 13.42%4.21B | 16.20%3.92B | 18.46%3.81B | 20.89%3.75B | 22.96%3.71B | 27.85%3.37B | 37.93%3.21B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
